France Biotech cordially extends an invitation for you to join us in an enlightening webinar titled, "Perspectives on Market Access in the UK and Europe for Medicines" - a collaborative effort with Genchrome and the Bioindustry Association (BIA).

Dive into key topics such as enhancing patient access strategies and increasing asset value, all under the scope of biotech market access. Our panel of industry leaders is set to unveil their proven strategies, valuable experiences, and insights.

Engage in a riveting dialogue with market access experts as they delve into the challenges and opportunities that this field presents.

Seize this singular opportunity, brought to you by France Biotech, Genchrome, and the Bioindustry Association (BIA), to deepen your comprehension of market access within the contexts of the UK and European markets. You wouldn't want to miss this!

____________________________________________________________________________________________

Projected program* :

Moderators :

Frédéric Girard, Vice President and Coordinator of the market access working group of France Biotech

Caroline Boulliat, CEO & Founder, Genchrome - CCE- Lead Comite Sante UK

Speakers :

12.30 - Introduction

Frédéric Girard, Vice President and Coordinator of the market access working group of France Biotech

12.35 - Thinking ahead for patient access & asset value

Laure Nas de Tourris, Global Commercial Lead Immunology And Rare Disease, Kyowa Kirin- Member Comite Sante- UK

12.55 - Approach to Market Access the Experience from a Biotech

Mark Waker, Patient (“Market”) Access, Mereo Biopharma

13:15 - Panel Discussion

Kawitha Helme, European Market Access Expert, Genchrome

Laure Nas de Tourris, Global Commercial Lead Immunology And Rare Disease, Kyowa Kirin

Mark Waker, Patient (“Market”) Access, Mereo Biopharma

____________________________________________________________________________________________

Free participation for member companies of France Biotech. Verify if your company is a member of France Biotech here.

Free participation for member companies of Bioindustry Association (BIA). Verify if your company is a member of Bioindustry Association (BIA) here.

Rates for attendees from non-member companies of France Biotech or Bioindustry Association (BIA) :

€100 excluding taxes for a HealthTech company

€300 excluding taxes for a consulting or service company

Membership starting from €200 excluding taxes per year: https://france-biotech.fr/france-biotech/adhesion/

After your registration, a webinar access link will be shared with you a few days prior to the event.

____________________________________________________________________________________________

Don't delay, register now!

*Program subject to potential adjustments.

Overview of Market Access in the UK and European Perspectives for Medicines